Page last updated: 2024-10-29

indomethacin and Carcinoma, Small Cell

indomethacin has been researched along with Carcinoma, Small Cell in 6 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Groot, DJ2
Timmer, T1
Spierings, DC1
Le, TK2
de Jong, S2
de Vries, EG2
van der Deen, M1
Regeling, A1
Meeker, J1
Lachiewicz, PF1
Kobayashi, S1
Okada, S1
Hasumi, T1
Sato, N1
Fujimura, S1
Stanojević-Bakić, N1
Vucković-Dekić, L1
Susnjar, S1
Spuzić, I1
Kas'ianenko, IV1
Pivniuk, VM1
Lisitsa, AM1
Kovalenko, NA1
Bagirian, MA1

Other Studies

6 other studies available for indomethacin and Carcinoma, Small Cell

ArticleYear
Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells.
    British journal of cancer, 2005, Apr-25, Volume: 92, Issue:8

    Topics: Antibiotics, Antineoplastic; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Blotting, West

2005
Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1.
    British journal of cancer, 2007, Oct-22, Volume: 97, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassett

2007
An unusual cause of late pain and effusion after total knee arthroplasty: pulmonary hypertrophic osteoarthropathy. A case report.
    The Journal of bone and joint surgery. American volume, 2008, Volume: 90, Issue:2

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Knee; Carcinoma, Small Cel

2008
The marked anticancer effect of combined VCR, MTX, and indomethacin against drug-resistant recurrent small cell lung carcinoma after conventional chemotherapy: report of a case.
    Surgery today, 1999, Volume: 29, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclooxygenase Inhibitors; Dr

1999
In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
    Neoplasma, 1992, Volume: 39, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Humans; Immun

1992
[The immunomodulating role of indomethacin in the chemoradiation treatment of inoperable patients with lung cancer].
    Voprosy onkologii, 1992, Volume: 38, Issue:10

    Topics: Adenocarcinoma; Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, S

1992